In summary, our comprehensive analysis of > 300 primary AML samples demonstrates antigen positivity of CD33, CD123, CLL1, TIM3 and CD244 in most cases at initial diagnosis and relapse, irrespective of the genetic background. The gene discussed is CD244; the disease is acute myeloid leukemia.